Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: A double-blind, randomized pilot study

Clinical Therapeutics

Volumn 22, Issue 4, 2000, Pages 411-419

  Brenner, Ronald ^a   Azbel, Vadim ^b   Madhusoodanan, Subramoniam ^a   Pawlowska, Monika ^a  

^a ST JOHN S EPISCOPAL HOSPITAL   (United States)

^b CABRINI MEDICAL CENTER   (United States)

Author keywords

Depression; Hypericum; Sertraline; St. John's wort

Indexed keywords

HYPERICUM EXTRACT; SERTRALINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0034124646     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)89010-4     Document Type: Article

References (25)

1. 1. Gerard J. The Herball or General Historie of Plants. London: 1597.
2. 2. Banckes R. Here Begynneth a New Mater, the Which Sheweth and Treateth of Ye Vertues and Propyrtes of Herbes, the Whiche Is Called an Herball. London: 1525.
3. 3. Millsbaugh CE. American Medicinal Plants: An Illustrated and Descriptive Guide to Plants Indigenous to and Naturalized in the United States Which Are Used in Medicine. Philadelphia: 1892. Reprint. New York: Dover; 1974.
4. 4. Porcher FP. Resources of the Southern Fields and Forests, Medical, Economical, and Agricultural . . . Prepared and Published by Order of the Surgeon-General. Richmond, Va: 1863. Reprint. New York: Arno Press; 1970.
5. 5. Grieve M. A Modern Herbal. The Medicinal, Culinary, Cosmetic and Economic Properties, Cultivation and Folk-Lore of Herbs, Grasses, Fungi, Shrubs and Trees. 1931. Reprint. New York: Dover; 1971.
6. 6. Linde K, Ramirez G, Mulrow CD, et al. St John's wort for depression - an overview and meta-analysis of randomised clinical trials. Br Med J. 1996;313:253-258.
7. 7. Kim HL, Streltzer J, Goebert D. St. John's wort for depression: A meta-analysis of well-defined clinical trials. J Nerv Ment Dis. 1999;187:532-539.
8. 8. Hansgen KD, Vesper J, Ploch M. Multicenter double-blind study examining the antidepressant effectiveness of the hypericum extract LI 160. J Geriatr Psychiatry Neurol. 1994;7(Suppl 1):S15-S18.
9. 9. Witte VB, Harrer G, Katan T, et al. Treatment of depressive symptoms with a high concentration hypericum preparation: A multicenter placebo-controlled double-blind study. Fortschr Med. 1995;113:404-408.
10. 10. Bergmann R, Nubner J, Demling J. Behandlung leichter bis Mittelschwerer Depressionen. Therapiewoche Neurologiel Psychiatrie. 1993;7:235-240.
11. 11. Harrer G, Hubner WD, Podzuwelt H. Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: A multicenter double-blind study. J Geriatr Psychiatry Neurol. 1994;7 (Suppl 1):S24-S28.
12. 12. Vorbach EU, Arnoldt KH, Hubner WD. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiatry. 1997;30(Suppl 2):81-85.
13. 13. Wheatley D. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients - a controlled 6-week clinical trial. Pharmacopsychiatry. 1997;30(Suppl 2):77-80.
14. 14. Hamilton M. Rating depressive patients. J Clin Psychiatry. 1980;41:21-24.
15. 15. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
16. 16. Aguglia E, Casacchia M, Cassano GB, et al. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression. Int Clin Psychopharmacol. 1993;8:197-202.
17. 17. Bennie EH, Mullin JM, Martindale JJ. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression. J Clin Psychiatry. 1995;56:229-237.
18. 18. Zerssen D v. Klinische Selbstbeurteilungsskalen (Ksb-S) aus dein Münchner Psychiatrischen Informations-System. Paranoid-Depressivitäts-Skala sowie Depressivitäts-Skala. Manual. Weinheim, Germany: Beltz Test; 1976.
19. 19. Lydiard RB, Stahl SM, Hertzman M, Harrison WM. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression. J Clin Psychiatry. 1997;58:484-491.
20. 20. Keller MB, Kocsis JH, Thase ME, et al. Maintenance phase efficacy of sertraline for chronic depression: A randomized controlled trial. JAMA. 1998;18:1665-1672.
21. 21. Ernst E, Rand JI, Barnes J, Stevinson C. Adverse effects profile of the herbal antidepressant St. John's wort. Eur J Clin Pharnmcol. 1998;54:589-594.
22. 22. Josey ES, Tackett RL. St. John's wort: A new alternative for depression? Int J Clin Pharmacol Ther. 1999;37:111-119.
23. 23. Bennett DA, Phun L, Polk JF, et al. Neuropharmacology of St. John's wort (hypericum). Ann Pharmacother. 1998;32: 1202-1208.
24. 24. Neary JT, Bu Y. Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Res. 1999; 816:358-363.
25. +. J Pharmacol Exp Ther. 1999;290: 1363-1368.